Correlation Between Syndax Pharmaceuticals and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Revelation Biosciences, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Revelation Biosciences.
Diversification Opportunities for Syndax Pharmaceuticals and Revelation Biosciences
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Syndax and Revelation is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Revelation Biosciences
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 9.59 times less return on investment than Revelation Biosciences. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 4.58 times less risky than Revelation Biosciences. It trades about 0.06 of its potential returns per unit of risk. Revelation Biosciences is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 0.68 in Revelation Biosciences on December 29, 2024 and sell it today you would earn a total of 0.50 from holding Revelation Biosciences or generate 73.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.08% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Revelation Biosciences
Performance |
Timeline |
Syndax Pharmaceuticals |
Revelation Biosciences |
Syndax Pharmaceuticals and Revelation Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Revelation Biosciences
The main advantage of trading using opposite Syndax Pharmaceuticals and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Revelation Biosciences vs. Revelation Biosciences | Revelation Biosciences vs. SAB Biotherapeutics | Revelation Biosciences vs. Surrozen Warrant | Revelation Biosciences vs. Thayer Ventures Acquisition |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |